By Amy Banks
Magstim has been awarded FDA clearance for the Horizon 3.0 with StimGuide Pro. This provides physicians, nurse practitioners, clinicians, and researchers with the most advanced transcranial magnetic stimulation technology (TMS) available to treat patients diagnosed with depressive or obsessive-compulsive conditions*.
By Amy Banks
We recently spoke with Dr Brian Forsythe, of Dallas Psychiatry TMS Clinic, to find out about the positive impact that StimGuide has had on his practice and patients.
By Amy Banks
Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio High-density EEG complements Magstim’s Transcranial Magnetic Stimulation Technology Driving Innovation MINNEAPOLIS, Minn. & Carmarthenshire, UK — (July 2, 2020) – Magstim, the global leader in Transcranial Magnetic Stimulation (TMS), today announced an agreement to acquire the product portfolio of Electrical Geodesics, Inc. (EGI) from Royal Philips (NYSE:PHG; … Continued
By Amy Banks
Magstim Academy Lecture Series – Rhythm and Acceleration – recent advances in TMS treatment for mood disorders. Mark George, MD, Nolan Williams, MD and Martijn Arns, PhD will present on their recently published and on-going TMS studies.
By Amy Banks
Magstim Academy Lecture Series – this live series will begin on May 12th and cover cutting-edge magnetic stimulation research.
By Amy Banks
In accordance with guidelines recommended by the CDC and other health organizations, many TMS treatment clinics are still operational. This is an example of a TMS center that continues to operate and support both existing and new patients.
By Amy Banks
Magstim® TMS has launched the very first Transcranial Magnetic Stimulation navigation system specifically developed for the clinical market.
By Amy Banks
A 34 year old man, who suffered from depression for 20 years and endured 13 courses of antidepressants with no effect, is calling for greater awareness of a non-invasive treatment that treats depression with magnetic pulses to stimulate brain activity.
By Amy Banks
Magstim has received FDA clearance to include intermittent Theta Burst Stimulation (iTBS) as a treatment for Major Depressive Disorder with its Horizon® TMS Therapy systems.
By Amy Banks
Neuromodulation has been studied in various forms for decades resulting in a range of clinical therapies and emerging applications including transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS) and electroconvulsive therapy (ECT) to name a few. We hope to answer some questions about neuromodulation here.